| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.007 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.008 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |